SOLID ADVANCED TUMOR
Clinical trials for SOLID ADVANCED TUMOR explained in plain language.
Never miss a new study
Get alerted when new SOLID ADVANCED TUMOR trials appear
Sign up with your email to follow new studies for SOLID ADVANCED TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immune drug OSE-279 takes on advanced tumors
Disease control Recruiting nowThis study tests a new drug called OSE-279 that helps the immune system fight cancer. It is for people with advanced solid tumors or lymphomas that have not responded to other treatments. The trial has three parts: finding the right dose, checking safety, and measuring how well t…
Matched conditions: SOLID ADVANCED TUMOR
Phase: PHASE1, PHASE2 • Sponsor: OSE Immunotherapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New drug duo targets tough cancers in early trial
Disease control Recruiting nowThis study tests a combination of two drugs, MCLA-129 and ensartinib, in people with advanced solid tumors that cannot be cured. The drugs work by blocking certain proteins that help cancer grow. The trial has two phases: first to find the safest dose, then to see if the combo sh…
Matched conditions: SOLID ADVANCED TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Betta Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC